Crohn's diseases & osteoimmunology - Is vitamin D the cross-talk co-ordinator?

Indian Journal of Medical Research

Volumn 130, Issue 2, 2009, Pages 108-111

  Harinarayan, C V ^a  

^a SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; GAMMA INTERFERON; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; VITAMIN D RECEPTOR; BONE DENSITY CONSERVATION AGENT; TNFSF11 PROTEIN, HUMAN; VITAMIN D;

ANOREXIA; BONE DENSITY; BONE DEVELOPMENT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CROHN DISEASE; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; IMMOBILIZATION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; METABOLIC BONE DISEASE; MUCOSAL IMMUNITY; NOTE; SIDE EFFECT; SUN EXPOSURE; TH1 CELL; TH2 CELL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BONE; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY;

BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; CROHN DISEASE; GLUCOCORTICOIDS; HUMANS; OSTEOPROTEGERIN; RANK LIGAND; VITAMIN D;

EID: 70349529683     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Note

References (12)

1. Joseph AJ, George B, Pulimood AB, Seshadri MS, Chacko A. 25(OH) vitamin D levels in Crohn's disease: association with sun exposure & disease activity. Indian J Med Res 2009; 130: 133-7.
2. Peyrin-Biroulet L, Oussalah A, Bigard MA. Crohn's disease: The hot hypothesis. Med Hypothesis 2009; 73: 94-6.
3. Loftus Jr EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence and environmental influences. Gastroenterology 2004; 126: 1504-17.
4. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC.1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 1985; 134: 3032-5.
5. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 1995; 125 (6 Suppl): 1704S-8S.
6. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000; 164: 4443-51.
7. Peyrin-Biroulet L, Desreumaux P, Sandborn WJ, Colombel JF. Crohn's disease: beyond antagonists of tumour necrosis factor. Lancet 2008; 372: 67-81.
8. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-3.
9. Moschen AR, Kaser A, Enrich B, Ludwiczek O, Gabriel M, Obrist P, et al. The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Gut 2005; 54: 479-87.
10. Ulrich SE. Sunlight and skin cancer: lessons from the immune system. Mol Carcinog 2007; 46: 629-33.
11. Franchimont N, Reenaers C, Lambert C, Belaiche J, Bours V, Malaise M, et al. Increased expression of receptor activator of NF- B ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clin Exp Immunol 2004; 138: 491-8.
12. Anderson PH, Sawyer RK, Moore AJ, May BK, O'Loughlin PD, Morris HA. Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model. J Bone Miner Res 2008; 23: 1789-97.